Variation in NF- B Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer
View/ Open
Author
Block, M. S.
Charbonneau, B.
Vierkant, R. A.
Fogarty, Z.
Bamlet, W. R.
Pharoah, P. D. P.
Rossing, M. A.
Pearce, C. L.
Schildkraut, J.
Menon, U.
Kjaer, S. K.
Levine, D. A.
Gronwald, J.
Culver, H. A.
Whittemore, A. S.
Karlan, B. Y.
Lambrechts, D.
Wentzensen, N.
Kupryjanczyk, J.
Chang-Claude, J.
Bandera, E. V.
Hogdall, E.
Heitz, F.
Kaye, S. B.
Fasching, P. A.
Campbell, I.
Goodman, M. T.
Pejovic, T.
Bean, Y. T.
Hays, L. E.
Lurie, G.
Eccles, D.
Hein, A.
Beckmann, M. W.
Ekici, A. B.
Paul, J.
Brown, R.
Flanagan, J. M.
Harter, P.
du Bois, A.
Schwaab, I.
Hogdall, C. K.
Lundvall, L.
Olson, S. H.
Orlow, I.
Paddock, L. E.
Rudolph, A.
Eilber, U.
Dansonka-Mieszkowska, A.
Rzepecka, I. K.
Ziolkowska-Seta, I.
Brinton, L. A.
Yang, H.
Garcia-Closas, M.
Despierre, E.
Lambrechts, S.
Vergote, I.
Walsh, C. S.
Lester, J.
Sieh, W.
McGuire, V.
Rothstein, J. H.
Ziogas, A.
Lubi ski, J.
Cybulski, C.
Menkiszak, J.
Jensen, A.
Gayther, S. A.
Ramus, S. J.
Gentry-Maharaj, A.
Berchuck, A.
Wu, A. H.
Pike, M. C.
Van Den Berg, D.
Vitonis, A. F.
Ramirez, S. M.
Rider, D. N.
Knutson, K. L.
Sellers, T. A.
Phelan, C. M.
Doherty, J. A.
Johnatty, S. E.
deFazio, A.
Song, H.
Tyrer, J.
Kalli, K. R.
Fridley, B. L.
Cunningham, J. M.
Goode, E. L.
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1158/1055-9965.EPI-13-0962Metadata
Show full item recordCitation
Block, M. S., B. Charbonneau, R. A. Vierkant, Z. Fogarty, W. R. Bamlet, P. D. P. Pharoah, M. A. Rossing, et al. 2014. “Variation in NF- B Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer.” Cancer Epidemiology Biomarkers & Prevention 23 (7) (April 16): 1421–1427. doi:10.1158/1055-9965.epi-13-0962.Abstract
Survival in epithelial ovarian cancer (EOC) is influenced by the host immune response, yet the key genetic determinants of inflammation and immunity that impact prognosis are not known. The nuclear factor-kappa B (NF-κB) transcription factor family plays an important role in many immune and inflammatory responses, including the response to cancer. We studied common inherited variation in 210 genes in the NF-κB family in 10,084 patients with invasive EOC (5,248 high grade serous, 1,452 endometrioid, 795 clear cell, and 661 mucinous) from the Ovarian Cancer Association Consortium. Associations between genotype and overall survival were assessed using Cox regression for all patients and by major histology, adjusting for known prognostic factors and correcting for multiple testing (threshold for statistical significance—p < 2.5×10−5). Results were statistically significant when assessed for patients of a single histology. Key associations were with CARD11 (caspase recruitment domain family, member 11) rs41324349 in patients with mucinous EOC (HR 1.82, 95% CI 1.41–2.35, p=4.13×10−6) and TNFRSF13B (tumor necrosis factor receptor superfamily, member 13B) rs7501462 in patients with endometrioid EOC (HR 0.68, 95% CI 0.56–0.82, p=2.33×10−5). Other associations of note included TRAF2 (TNF receptor-associated factor 2) rs17250239 in patients with high-grade serous EOC (HR 0.84, 95% CI 0.77–0.92, p=6.49×10−5) and PLCG1 (phospholipase C, gamma 1) rs11696662 in patients with clear cell EOC (HR 0.43, 95% CI 0.26–0.73, p=4.56×10−4). These associations highlight the potential importance of genes associated with host inflammation and immunity in modulating clinical outcomes in distinct EOC histologies.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082406/Terms of Use
This article is made available under the terms and conditions applicable to Open Access Policy Articles, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#OAPCitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:27336522
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)